National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

etanercept
A recombinant soluble dimeric fusion protein consisting of the extracellular ligand-binding region of recombinant human tumor necrosis factor (rhTNF) receptor attached to the constant (Fc) region of human immunoglobulin G (FcIgG). The receptor moiety of etanercept binds to circulating TNF (2 molecules of TNF per receptor) and inhibits its attachment to endogenous TNF cell surface receptors, thereby rendering TNF inactive and inhibiting TNF-mediated mechanisms of inflammation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Tumor Necrosis Factor Receptor IgG Chimera
US brand name:Enbrel
Abbreviations:ETN
TNFR:Fc



Previous:estramustine phosphate sodium, ESTRING, Estrobene, EstroGel, Estrosyn
Next:etanidazole, etaracizumab, ethacrynic acid, ethanol, Ethinoral

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov